معرفی
Chianna Dane serves as an Associate Lecturer in the Sydney Pharmacy School within the Faculty of Medicine and Health at the University of Sydney. Her academic profile centers on medicinal chemistry and drug discovery, with specific expertise in adamantane-based therapeutics and synthetic cannabinoid receptor pharmacology.
Her research interests include:
- Medicinal Chemistry: Design and synthesis of novel adamantane derivatives for enhanced drug properties
- Pharmacology: Structure-activity relationships of synthetic cannabinoids targeting neurological pathways
- Drug Discovery: Optimization of lipophilic scaffolds and receptor-specific modifications
- Receptor Biochemistry: Mechanistic studies of P2X and cannabinoid receptor interactions
Analysis of her 2022-2025 publications reveals a consistent focus on chemical modifications—including deuteration, fluorination, and amino acid derivatization—to improve metabolic stability and therapeutic efficacy of synthetic cannabinoids. Her work bridges organic chemistry with neuropharmacology, targeting pain management and inflammatory conditions through receptor-specific drug design.
Dr. Dane is an active member of The Centre for Drug Discovery Innovation, where she contributes to interdisciplinary collaborations focused on translating chemical research into clinical applications. While specific grant details and student supervision records are not publicly documented, her publication record demonstrates extensive collaboration with medicinal chemistry researchers across Australian and international institutions.
